- Nelson Advisors LLP
- About Us
- Contact Us
- Message Us
- Meet Us
- FAQ's
- Mission and Vision
- Expertise
- Services
- Lower to Mid Market
- Corporate Divestitures
- Healthcare AI
- Digital Health
- Transactions
- Behaviour Change
- App Platform Data AI
- Research
- University Business Schools
- Thought Leadership
- Careers
- Lloyd G Price
- Press and Awards
- Blog
- Insights
- Newsletter
Nelson Advisors: The $25M to $250M European Digital Health, HealthTech, MedTech, Health AI Exit Playbook
NA
Most HealthTech exits between $25M and $250M of enterprise value are won or lost long before a buyer sees a teaser. The price is set by what diligence finds, and what diligence finds is set by the 18 months of preparation that came before it.
Founders often treat a sale as an event. They hire an adviser, build a data room in six weeks, and hope the story carries the numbers. In this size range it rarely does.
A $40M digital health company does not have the finance team, legal function or regulatory department of a $2Bn strategic. Yet the buyer's diligence team will ask the same questions of both. The gaps that a large company closes as routine become, for a smaller one, price chips, escrows, earn-outs or a broken deal.
The good news is that almost every one of those gaps is fixable with time. An unassigned patent, a missing technical file, a revenue recognition policy that will not survive an audit, a single customer at 40% of revenue: none of these is fatal at month 18. All of them are expensive at month one.
Our Nelson Advisors playbook sets out what to fix and when, across the four areas where lower-to-mid-market HealthTech, MedTech, Digital Health and Health AI deals most often lose value: financials, intellectual property, regulatory files and customer concentration. It ends with the final six months, when preparation turns into a process.